Early stage life sciences company iBIONICS has had “a phenomenal year of growth and learning,” says CEO and co-founder Suzanne Grant.
The company, which is developing a bionic-eye system to restore vision in people with retinal degenerative diseases, has reached combined private and public funding goals of US$2.5 million and added another $1.5 million in grants; it also expects to finalize additional pre-seed financing in the next two quarters.
The firm has secured an exclusive worldwide licence for its prototype and has recently celebrated several other business and technical milestones.
OBJ360 (Sponsored)
How the uOttawa faculty of engineering instills an ‘entrepreneurial mindset’ in students
A decade ago, Terrafixing chief operating officer Vida Gabriel was a chemistry-loving student in high school with little to no interest in business or entrepreneurship. “I didn’t like the sales
Last month Ottawa Salus launched “Opening Doors to Dignity,” a $5 million campaign to construct a 54-unit independent living building on Capilano Drive. Set to open in late 2025, this
Ms. Grant and iBIONICS were also chosen to exhibit at the Accessibility Innovation Showcase at the Invictus Games in Toronto in September.
